The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,326.00
Bid: 9,324.00
Ask: 9,330.00
Change: -54.00 (-0.58%)
Spread: 6.00 (0.064%)
Open: 9,352.00
High: 9,400.00
Low: 9,296.00
Prev. Close: 9,380.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

1 May 2024 07:00

RNS Number : 6991M
Next PLC
01 May 2024
 

 

Date:

Embargoed until 07:00 hrs, Wednesday 1 May 2024

Contacts:

Amanda James, Group Finance Director (analyst calls)

 

NEXT PLC

Tel: 0333 777 8888

 

Alistair Mackinnon-Musson

Email: next@rowbellpr.com

 

Rowbell PR

Tel: 020 7717 5239

Photographs:

https://www.nextplc.co.uk/media/image-gallery/campaign-images

 

Trading Statement - 1 May 2024

HEADLINES

·

In the thirteen weeks to 27 April NEXT Trading full price sales1 were up +5.7% versus last year, slightly ahead of our guidance for this period, which was to be up +5%.

·

We are maintaining our sales and profit guidance for the full year, with NEXT Group profit2 before tax forecast to be £960m (+4.6%).

1. NEXT Trading full price sales include items sold in Retail and Online plus NEXT Finance interest income, but excludes Sale events, Clearance, Total Platform commission and the sales from subsidiaries. 

2. NEXT Group profit before tax excludes: (1) the cost of brand amortisation, (2) the profit attributable to shares that we do not own in subsidiary companies, and (3) an exceptional, non-cash, loss relating to the closure of our defined benefit pension scheme. 

FULL PRICE SALES PERFORMANCE BY BUSINESS DIVISION

Full price sales by division

13 weeks to 27 April

2024/25 vs 2023/24

Online

+8.8%

Retail

+0.0%

Total Product full price sales

+5.7%

NEXT Finance interest income

+6.4%

Total NEXT Trading full price sales

+5.7%

GUIDANCE FOR SALES, PROFIT AND EARNINGS PER SHARE

Our guidance for the full year remains unchanged from that given in our Year End Results in March. For completeness, this guidance is repeated below. 

Guidance for the full year 2024/25

Full year £ (e)

% Versus 2023/24

NEXT Trading Full price sales

£4.9bn

+2.5%

Total Group sales including subsidiary companies and markdown sales

£6.2bn

+6.0%

NEXT Group profit before tax

£960m

+4.6%

Pre-tax EPS

805.2p

+6.3%

Post-tax EPS

606.3p

+4.8%

As stated in our Year End Report, and explained further in the notes below, Group sales in the year are expected to increase by more than NEXT full price sales. The difference is the result of the acquisition of equity stakes in FatFace and Reiss. 

A note on expected sales phasing for the rest of the year

We are maintaining our guidance for full price sales in the first half to be up +2.5%. This implies that our sales in Q2 will be down -0.3%. We expect the sales performance in the second quarter to be weaker than the first quarter because last year benefited from particularly warm weather from late May through to the end of June. 

For completeness, our guidance for the rest of the year is summarised below. 

Full price sales guidance

Q1 (actual)

Q2 (e)

Q3 (e)

Q4 (e)

2024/25 versus 2023/24

+5.7%

- 0.3%

+2.5%

+2.5%

Our next sales update will cover the first 26 weeks of the year to 27 July 2024 and is scheduled for Thursday 1 August 2024.

 

Notes on Total Group Sales

Total Group sales are the sum of total sales (full price and markdown) from all of the Group's divisions plus revenue from subsidiary companies. Subsidiaries' turnover is calculated using our share of our subsidiaries' turnover. For example, we own 72% of Reiss so we include 72% of their sales in our top line.

Total Group sales for the full year are expected to be up +6% on last year, which is 3.5% higher than our expected underlying growth in NEXT Trading full price sales of +2.5%. This difference in sales growth is explained by the timing of acquisitions completed during last year; we acquired 97% of FatFace in October 2023 and increased our equity share in Reiss from 51% to 72% in September 2023. 

Forward Looking Statements

Certain statements in this Trading Update are forward looking statements. These statements may contain the words "anticipate", "believe", "intend", "aim", "expects", "will", or words of similar meaning. By their nature, forward looking statements involve risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. As such, undue reliance should not be placed on forward looking statements. Except as required by applicable law or regulation, NEXT plc disclaims any obligation or undertaking to update these statements to reflect events occurring after the date these statements were published.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBLFXZZLLBBZ
Date   Source Headline
21st May 20246:09 pmRNSTransaction in Own Shares
20th May 20245:10 pmRNSTransaction in Own Shares
17th May 20245:09 pmRNSTransaction in Own Shares
16th May 20245:14 pmRNSTransaction in Own Shares
16th May 20242:58 pmRNSSection 430 (2B) Companies Act 2006 Statement
16th May 20242:12 pmRNSResult of AGM
1st May 20249:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTrading Statement
29th Apr 20244:30 pmRNSDirector/PCA Shareholding
26th Apr 20246:12 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.